Q2 2024 EPS Estimates for Amedisys, Inc. (NASDAQ:AMED) Boosted by Analyst

Amedisys, Inc. (NASDAQ:AMED) – Analysts at William Blair increased their Q2 2024 earnings per share estimates for Amedisys in a research report issued on Thursday, April 25th. William Blair analyst M. Larew now forecasts that the health services provider will post earnings per share of $1.18 for the quarter, up from their prior forecast of $1.04. The consensus estimate for Amedisys’ current full-year earnings is $4.54 per share. William Blair also issued estimates for Amedisys’ Q3 2024 earnings at $1.12 EPS and Q4 2024 earnings at $1.21 EPS.

Amedisys (NASDAQ:AMED) last posted its earnings results on Wednesday, April 24th. The health services provider reported $1.03 earnings per share for the quarter, beating analysts’ consensus estimates of $1.02 by $0.01. Amedisys had a positive return on equity of 13.00% and a negative net margin of 0.91%. The company had revenue of $571.41 million for the quarter, compared to analyst estimates of $565.38 million. During the same quarter last year, the company earned $1.00 earnings per share. The company’s revenue for the quarter was up 2.7% on a year-over-year basis.

A number of other analysts have also commented on the company. Cantor Fitzgerald reiterated a “neutral” rating and set a $101.00 price target on shares of Amedisys in a report on Thursday. Raymond James reiterated a “market perform” rating on shares of Amedisys in a report on Tuesday, March 26th. StockNews.com lowered Amedisys from a “buy” rating to a “hold” rating in a report on Friday. Finally, Royal Bank of Canada boosted their target price on Amedisys from $97.00 to $100.00 and gave the company an “outperform” rating in a research note on Monday, March 25th. Eight equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $97.50.

Amedisys Stock Performance

Shares of Amedisys stock opened at $91.79 on Friday. The business’s fifty day simple moving average is $92.54 and its 200 day simple moving average is $93.35. The firm has a market capitalization of $3.00 billion, a P/E ratio of -143.42, a price-to-earnings-growth ratio of 4.29 and a beta of 0.86. Amedisys has a 12 month low of $73.10 and a 12 month high of $96.44. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.32.

Hedge Funds Weigh In On Amedisys

Several hedge funds have recently made changes to their positions in AMED. Banque Cantonale Vaudoise purchased a new position in shares of Amedisys in the first quarter valued at $60,000. Cetera Trust Company N.A purchased a new position in Amedisys during the fourth quarter worth about $215,000. CWM LLC grew its position in Amedisys by 40.4% during the fourth quarter. CWM LLC now owns 2,629 shares of the health services provider’s stock worth $250,000 after buying an additional 757 shares in the last quarter. Contravisory Investment Management Inc. purchased a new position in Amedisys during the fourth quarter worth about $258,000. Finally, Mesirow Institutional Investment Management Inc. grew its position in Amedisys by 9.9% during the fourth quarter. Mesirow Institutional Investment Management Inc. now owns 2,844 shares of the health services provider’s stock worth $270,000 after buying an additional 257 shares in the last quarter. 94.36% of the stock is currently owned by hedge funds and other institutional investors.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.